Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency

Extended Clinical Study of LY137998 [Somatropin (Recombinant DNA Origin)] in Adults With Growth Hormone Deficiency

To evaluate long-term safety of growth hormone replacement in adult patients with growth hormone deficiency

Inclusion Criteria:

• Having completed the preceding long-term study of growth hormone replacement in adult patients diagnosed with growth hormone deficiency.
• Other pituitary hormone deficiencies being replaced if appropriate

Exclusion Criteria:

• With severe impairments of cardiac, pulmonary, renal or hepatic functions
• With severe psychological disorders
• With malignant cancer
• With hypertension uncontrolled
• With diabetes mellitus